Lena Ahmarani
Montreal, QC H3T1C5, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Magnetic Resonance Imaging-Based Assessment of Bone Marrow Fat and T2 Relaxation in Adolescents with Obesity and Liver Steatosis: A Feasibility Pilot Study.
Journal: Journal of clinical medicine
Published: September 03, 2025
High-fat diet reveals the impact of Sar1b defects on lipid and lipoprotein profile and cholesterol metabolism.
Journal: Journal of lipid research
Published: May 05, 2023
Cranberry Proanthocyanidins as a Therapeutic Strategy to Curb Metabolic Syndrome and Fatty Liver-Associated Disorders.
Journal: Antioxidants (Basel, Switzerland)
Published: November 04, 2022
Glycomacropeptide for Management of Insulin Resistance and Liver Metabolic Perturbations.
Journal: Biomedicines
Published: August 06, 2021
Sar1b mutant mice recapitulate gastrointestinal abnormalities associated with chylomicron retention disease.
Journal: Journal of lipid research
Published: February 25, 2021
Intestinal protection by proanthocyanidins involves anti-oxidative and anti-inflammatory actions in association with an improvement of insulin sensitivity, lipid and glucose homeostasis.
Journal: Scientific reports
Published: July 23, 2020
SAR1B GTPase is necessary to protect intestinal cells from disorders of lipid homeostasis, oxidative stress, and inflammation.
Journal: Journal of lipid research
Published: May 06, 2019
Whole-cell and nuclear NADPH oxidases levels and distribution in human endocardial endothelial, vascular smooth muscle, and vascular endothelial cells.
Journal: Canadian journal of physiology and pharmacology
Published: February 02, 2013
Receptors and ionic transporters in nuclear membranes: new targets for therapeutical pharmacological interventions.
Journal: Canadian journal of physiology and pharmacology
Published: July 13, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026